MidAtlantic Diagnostics

MidAtlantic Diagnostics was a specialized medical technology company focused on the development and distribution of diagnostic products for assisted reproductive technology (ART). Based in Medford, New Jersey, the company became a leader in the andrology field through its innovative sperm processing media and antibody detection kits. Its flagship products, such as SpermMar and SpermSelect, provided clinicians with reliable methods for evaluating male fertility factors. In 2012, the company was acquired by CooperSurgical, a major provider of women's healthcare products. This acquisition allowed CooperSurgical to strengthen its position in the global fertility market by incorporating MidAtlantic's established diagnostic portfolio. Today, the legacy of MidAtlantic Diagnostics continues through the integrated fertility solutions offered by its parent organization.